Trial Outcomes & Findings for Home Sleep and Circadian Phase: Mediators of Diabetes Risk (NCT NCT01786564)
NCT ID: NCT01786564
Last Updated: 2020-11-27
Results Overview
The oral disposition index is based on the glucose and insulin levels during the first 30 minutes of a frequently sampled 5-hour oral glucose tolerance test. It reflects the combination of insulin sensitivity and insulin release in response to the glucose challenge. Higher values suggest a greater response.
COMPLETED
120 participants
baseline
2020-11-27
Participant Flow
Of 120 participants enrolled in the study, 56 were eligible, continued in the study and provided some data.
Participant milestones
| Measure |
Study Sample
This is a cross-sectional study so there is only one group.
|
|---|---|
|
Overall Study
STARTED
|
120
|
|
Overall Study
COMPLETED
|
56
|
|
Overall Study
NOT COMPLETED
|
64
|
Reasons for withdrawal
| Measure |
Study Sample
This is a cross-sectional study so there is only one group.
|
|---|---|
|
Overall Study
Lost to Follow-up
|
47
|
|
Overall Study
Ineligible
|
17
|
Baseline Characteristics
Three participants did not have valid actigraphy data so habitual sleep measures could not be calculated. Thus only 53 participants have habitual sleep measures.
Baseline characteristics by cohort
| Measure |
Study Sample
n=56 Participants
This is a cross-sectional study so there is only one group.
|
|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=56 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
56 Participants
n=56 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=56 Participants
|
|
Age, Continuous
|
30 years
STANDARD_DEVIATION 8.4 • n=56 Participants
|
|
Sex: Female, Male
Female
|
29 Participants
n=56 Participants
|
|
Sex: Female, Male
Male
|
27 Participants
n=56 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=56 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=56 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=56 Participants
|
|
Race (NIH/OMB)
Black or African American
|
27 Participants
n=56 Participants
|
|
Race (NIH/OMB)
White
|
29 Participants
n=56 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=56 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=56 Participants
|
|
Region of Enrollment
United States
|
56 participants
n=56 Participants
|
|
Body Mass Index (BMI), kg/m2
|
27.7 kg/m2
STANDARD_DEVIATION 5.3 • n=56 Participants
|
|
Habitual Sleep Duration (hours)
|
402 minutes
STANDARD_DEVIATION 39 • n=53 Participants • Three participants did not have valid actigraphy data so habitual sleep measures could not be calculated. Thus only 53 participants have habitual sleep measures.
|
|
Habitual sleep efficiency (% of sleep period sleeping)
|
90.8 percentage
STANDARD_DEVIATION 3.5 • n=53 Participants • Three participants did not have valid actigraphy data so habitual sleep measures could not be calculated. Thus only 53 participants have habitual sleep measures.
|
|
Habitual sleep start time (clock time)
|
0.27 Hours after midnight
STANDARD_DEVIATION 1.51 • n=53 Participants • Three participants did not have valid actigraphy data so habitual sleep measures could not be calculated. Thus only 53 participants have habitual sleep measures.
|
|
Duration of Stage 2 sleep (minutes)
|
190.6 Minutes
STANDARD_DEVIATION 77.4 • n=51 Participants • Five participants did not have a valid PSG recording. Thus only 51 participants have sleep stage data.
|
|
Duration of Stage 3 sleep (minutes)
|
68.4 Minutes
STANDARD_DEVIATION 30.7 • n=51 Participants • Five participants did not have a valid PSG recording. Thus only 51 participants have sleep stage data.
|
|
Duration of Rapid Eye Movement (REM) sleep (minutes)
|
96.5 Minutes
STANDARD_DEVIATION 49.1 • n=51 Participants • Five participants did not have a valid PSG recording. Thus only 51 participants have sleep stage data.
|
|
Fasting glucose levels (mg/dl)
|
86.8 mg/dl
STANDARD_DEVIATION 6.3 • n=54 Participants • 2 participants were missing valid fasting blood samples so only 54 have a HOMA measure.
|
|
Estimated Insulin Resistance (HOMA index method)
|
1.75 None (Index)
STANDARD_DEVIATION 1.82 • n=54 Participants • 2 participants were missing valid fasting blood samples so only 54 participants have HOMA estimated.
|
|
Oral Disposition Index at 30 minutes
|
11.5 None (Index)
STANDARD_DEVIATION 12.7 • n=53 Participants • 3 participants were missing some blood samples so the oral disposition index could not be calculated in these 3 participants. Thus, only 53 participants have this measure.
|
PRIMARY outcome
Timeframe: baselinePopulation: Three participants did not have adequate glucose and/or insulin values to calculate the disposition index.
The oral disposition index is based on the glucose and insulin levels during the first 30 minutes of a frequently sampled 5-hour oral glucose tolerance test. It reflects the combination of insulin sensitivity and insulin release in response to the glucose challenge. Higher values suggest a greater response.
Outcome measures
| Measure |
Study Sample
n=53 Participants
This is a cross-sectional study so there is only one group.
|
|---|---|
|
Oral Disposition Index
|
11.5 None (Index)
Standard Deviation 12.7
|
Adverse Events
Study Sample
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place